Labiana |
27 May
Labiana, the pharmaceutical laboratory specializing in both animal and human health and listed on BME Growth, will present its latest additions to its product portfolio at the ANEMBE International Congress of Bovine Medicine, taking place from May 28 to 30 in Vitoria. Among the highlights is a new antibiotic with zero milk withdrawal time in dairy cattle.
Labiana |
23 April
Labiana closed the 2024 fiscal year with revenues of €66.26 million, representing a 13.3% increase compared to the previous year.
Labiana |
25 March
Labiana, the pharmaceutical laboratory specialized in animal and human health listed on BME Growth, has added Lexylan, a new antibiotic classified as Category C in its prescription guidelines, to its product portfolio.
Labiana |
26 June
Labiana divests its Serbian subsidiary through a capital increase agreement
Labiana |
31 May
Labiana, el primer laboratorio veterinario español cotizado en Bolsa, ha hecho público su informe de resultados mostrando un incremento en su facturación en 2023
Labiana |
29 April
La alcaldesa de Corbera de Llobregat, Rosa Boladeras, acompañada de parte de su equipo de Gobierno visitaron durante la mañana del viernes 26 de abril las instalaciones de Labiana Pharmaceuticals.
